Mustang Bio logo
Mustang Bio MBIO
$ 0.75 -3.37%

Quarterly report 2026-Q1
added 05-05-2026

report update icon

Mustang Bio Total Current Liabilities 2011-2026 | MBIO

Annual Total Current Liabilities Mustang Bio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
7.91 M 12.6 M 15.4 M 15.1 M 10.8 M 9.52 M 7.77 M 5.62 M 3.61 M 3.22 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
15.4 M 3.22 M 9.16 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Exelixis Exelixis
EXEL
406 M $ 48.43 9.03 % $ 13.2 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
49.7 M $ 2.56 3.96 % $ 71.4 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Genprex Genprex
GNPX
2.17 M $ 0.9 2.02 % $ 839 K usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
47.5 M - - $ 269 M usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
782 M $ 76.96 2.27 % $ 12.3 B usaUSA
Kymera Therapeutics Kymera Therapeutics
KYMR
83.2 M $ 86.14 4.15 % $ 7.28 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
37.1 M $ 229.83 -1.06 % $ 4.2 B usaUSA
INmune Bio INmune Bio
INMB
8.42 M $ 1.52 -1.3 % $ 37.6 M usaUSA
Liquidia Corporation Liquidia Corporation
LQDA
136 M $ 41.84 4.26 % $ 3.6 B usaUSA
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
206 M $ 107.42 1.52 % $ 5.39 B usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
395 M $ 22.32 -0.13 % $ 3.7 B usaUSA
MannKind Corporation MannKind Corporation
MNKD
171 M $ 3.68 28.5 % $ 1.12 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
301 M $ 3.13 0.55 % $ 651 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.47 -8.44 % $ 5.71 M israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
130 M $ 23.86 1.88 % $ 3.04 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Puma Biotechnology Puma Biotechnology
PBYI
81.3 M $ 7.5 2.04 % $ 375 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA